Clinical imaging
-
Oncotype DX is a multigene assay used in breast cancer, and the result provided as a 'recurrence score (RS)' corresponds to the risk of a cancer recurrence and the chemotherapeutic benefit in estrogen receptor (ER)-positive human epidermal growth factor receptor (HER)2-negative invasive breast cancer. However, its accessibility is limited. ⋯ MRI features showed the potential for the discrimination of Oncotype DX RS in patients with ER-positive HER2-negative invasive breast cancer.
-
To investigate gender diversity in editorial boards among a wide range of radiology-related journals, the trend in time, and its association with the journal's impact factor (IF). ⋯ Women are underrepresented in a wide range of radiology-related journals. Comparison with historical data shows that the proportion of women on editorial boards has increased. Nevertheless, gender composition of the editorial board shows no association with IF. This suggests similar gender bias exists across a broad spectrum of high impact factor journals, with no added bias in journals with higher IF.